Home » Market News » DirectorsTalk Highlights » INTERVIEW: Widecells Group Strengthen Board and Update
WideCells Group PLC

INTERVIEW: Widecells Group Strengthen Board and Update

Widecells Group Plc (LON:WDC) CEO João Andrade and new Chairman Peter Presland join DirectorsTalk to discuss its latest update. João explains the reasons behind the board changes, what wideacademy is, why it was built and how this helps the company with its primary focus on increasing its global profile reach and sales. Peter provides us with his background and reasons for joining the company.

WideCells Group PLC is building an integrated stem cell services company, focused on making stem cell treatments both accessible and affordable.  This is delivered through three divisions:

·     CellPlan: the world’s first stem cell healthcare insurance plan with financial cover for medical treatment, travel and accommodation expenses and concierge service to manage the treatment process.

·     WideCells: The Institute of Stem Cell Technology has been established and is based in the University of Manchester Innovation Centre to focus on stem cell research and regenerative medicine. WideCells also has international cryogenics divisions specialising in stem cell storage.

·     Wideacademy: developing an education and training division to promote awareness of the benefits of stem cell storage across the global general practice community.

Receive our exclusive interviews – Enter your email to stay up to date.

Disclaimer: Statements in this article should not be considered investment advice, which is best sought directly from a qualified professional.